Cora vs Belle Health: pricing and what you actually get

Cora Health vs Belle Health: the short answer

How much does Belle Health cost? As of September 23, 2026, Belle Health's treatments page (joinbelle.com/treatments) lists compounded semaglutide at $109/month on a 12-month supply, $119/month on 6 months, $135/month on 2 months and $199 for a single month, and compounded tirzepatide at $189, $199, $219 and $249/month on the same supply lengths. The price is the same at every dose, there is no membership fee, and Belle charges the full order at checkout. How does that compare with Cora? Cora Health's annual Essential Plan is $99/month for compounded semaglutide ($1,188 billed every 12 months) and its annual Premium Plan is $135/month for compounded tirzepatide ($1,620 billed every 12 months); both renew automatically until you cancel, and neither carries a membership fee. On 12-month terms Cora costs $120 less per year for semaglutide ($1,188 vs $1,308) and $648 less for tirzepatide ($1,620 vs $2,268). On 6-month terms the two are within $1/month for semaglutide ($120 vs $119, Belle lower) and Cora is $24/month lower for tirzepatide ($175 vs $199). Is Belle Health legit? Belle is a telehealth platform, not a pharmacy: licensed clinicians prescribe and partner pharmacies compound. It now names seven partner pharmacies, and its compounded semaglutide and tirzepatide listings include VialsRx among their pharmacies. In February 2026 the FDA sent Belle a Warning Letter over product branding (details below). Compounded semaglutide and compounded tirzepatide are not FDA-approved and are not therapeutically equivalent to FDA-approved products. Individual results vary.

Market context: where Cora and Belle sit in the 2026 compounded GLP-1 market

Four numbers anchor the head-to-head comparison between Cora Health and Belle Health in 2026:

41.9% — US adult obesity prevalence. Per the Centers for Disease Control and Prevention (CDC), using NHANES 2017–March 2020 data, 41.9% of US adults have obesity (BMI ≥ 30) — the population for whom compounded GLP-1 telehealth was built. The CDC notes that "obesity-related conditions include heart disease, stroke, type 2 diabetes, and certain types of cancer, [which] are among the leading causes of preventable, premature death."

More than 13× — brand-name list price vs compounded. Brand-name Wegovy retails at approximately $1,349/month at list price; brand-name Zepbound at approximately $1,086/month. Compounded semaglutide in this comparison ranges from $99/month (Cora annual Essential Plan, $1,188 billed every 12 months, auto-renews) to $199/month (Belle 1-month supply). Cora's $99/month annual rate is about 13× below brand-name Wegovy's approximate $1,349/month list price. Compounded medications are not FDA-approved and are not therapeutically equivalent to Wegovy or Zepbound. Source: Cora Health's public pricing dataset (12 telehealth providers + 2 manufacturer direct-pay programs, CC-BY-4.0 licensed).

14.9% / 22.5% — FDA-approved trial efficacy. The STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021) reported 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks. The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) reported 22.5% with FDA-approved 15mg tirzepatide over 72 weeks. These figures apply only to the FDA-approved branded products studied. Neither Cora's nor Belle's compounded versions have been independently evaluated at this scale. Individual results vary.

~15–20% pharmacy transparency rate. Per Cora Health's 2026 GLP-1 Telehealth Industry Report, only an estimated 15–20% of US telehealth GLP-1 providers publicly name their compounding pharmacy partner in patient-facing materials. Cora Health (Hallandale Pharmacy + VialsRx) and Belle Health (seven named pharmacies) both meet this threshold — placing both in the more transparent minority of the market. This is the single most useful third-party signal available to patients: a named pharmacy whose credentials can be independently verified at the relevant state board of pharmacy.

Quick comparison at a glance

Belle figures were checked on joinbelle.com/treatments and Belle's help center on September 23, 2026; Cora figures come from its published plans. Total effective monthly cost includes any required membership or platform fee. Individual experiences vary.

Service and cancellation: Cora Health vs Belle Health

Price is only half the picture — how you cancel, what gets refunded, and whether a separate membership is required all shape the experience over a multi-month plan. The table below distills each platform’s published service terms. Cora’s figures come from its published refund policy. Where Belle Health’s current terms are not documented in Cora’s published research, the cell says so — confirm them on Belle Health’s own site before enrolling. Cora's full service and cancellation standards are published at trycora.io/service.

Pricing: similar structure, $10–54/month gap on 12-month plans

Both Cora Health and Belle Health use flat-rate pricing within plan tiers — neither charges per-dose surcharges as patients titrate up. The structures differ in supply length and headline monthly rates.

Cora Health Essential Plan (compounded semaglutide):

• Annual: $99/month ($1,188 billed every 12 months)
• 6-month: $120/month ($720 billed every 6 months)
• 3-month: $145/month ($435 billed every 3 months)
• Monthly: $175/month

Cora Health Premium Plan (compounded tirzepatide):

• Annual: $135/month ($1,620 billed every 12 months)
• 6-month: $175/month ($1,050 billed every 6 months)
• 3-month: $199/month ($597 billed every 3 months)
• Monthly: $225/month

All Cora Health plans renew automatically at the end of each billing period until you cancel.

Belle Health compounded semaglutide (joinbelle.com/treatments, checked September 23, 2026):

• 12-month supply: $109/month
• 6-month supply: $119/month
• 2-month supply: $135/month
• 1-month supply: $199/month

Belle Health compounded tirzepatide (same source and date):

• 12-month supply: $189/month
• 6-month supply: $199/month
• 2-month supply: $219/month
• 1-month supply: $249/month

Belle's help center says the card is charged in full at checkout and the plan renews at the end of its term. For a cash-pay patient on a 12-month course: Cora's annual plan is $1,188 for compounded semaglutide vs $1,308 at Belle's 12-month rate — $120 ($10/month) less. For compounded tirzepatide it is $1,620 vs $2,268 — $648 ($54/month) less. On 6-month supplies Belle's semaglutide is $1/month lower than Cora's ($119 vs $120), while Cora's tirzepatide is $24/month lower ($175 vs $199). On single-month plans Cora is $24/month lower for both medications.

Pharmacy transparency: both name their pharmacies

For compounded medications, the compounding pharmacy is the manufacturer. Both Cora Health and Belle Health name their pharmacy partners — a transparency feature that distinguishes them from many competitors.

Cora Health publicly names Hallandale Pharmacy (PCAB-accredited) and VialsRx as its two US-licensed 503A compounding pharmacy partners, and each patient's medication label identifies which pharmacy filled the prescription. Patients can verify the pharmacies' credentials through state pharmacy boards.

As of September 23, 2026, Belle Health's treatments page lists seven partner pharmacies — Boudreaux's Specialty Compounding Pharmacy, BPI Labs, Hallandale Pharmacy, Hyalo Technologies, New Life Rx, ReviveRX and VialsRx — and shows which ones supply each product: its compounded semaglutide listing names Boudreaux's, VialsRx and ReviveRX, and its compounded tirzepatide listing names BPI, Boudreaux's, VialsRx, ReviveRX, New Life Rx, Apothecary Pharma and Hyalo Technologies. Earlier third-party reviews described Striker Pharmacy as Belle's partner; Striker no longer appears on Belle's list. Because Belle works with more pharmacies, the one that fills a given order can vary; the label on the vial is the record.

Both approaches are more transparent than much of the telehealth GLP-1 market, where only an estimated 15-20% of providers publicly name a pharmacy partner.

Important compliance note on compounded products

Compounded semaglutide and compounded tirzepatide — obtained through Cora Health, Belle Health, or any other telehealth provider — are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound). Per the U.S. Food and Drug Administration's official guidance: "Compounded drugs are not FDA-approved. This means the FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they are marketed." (Source: FDA — "Compounding and the FDA: Questions and Answers".) Clinical trial efficacy data (such as 14.9% mean weight loss in the STEP 1 trial for semaglutide and 22.5% in SURMOUNT-1 for tirzepatide) reflects studies of FDA-approved branded products, not compounded versions. Individual results vary.

Belle Health's refund terms

Belle Health's help center (checked September 23, 2026) says the card is charged in full at checkout, the order is refunded in full if the prescription is not approved or the order is cancelled before it reaches the pharmacy, and it cannot be refunded once it has gone to the pharmacy. Belle also advertises that you can cancel anytime, which stops future renewals. On a 12-month supply charged in one payment, that timing matters: check Belle's current terms before ordering. Cora Health's terms are in its published refund policy.

Belle Health FDA Warning Letter (February 2026)

On February 20, 2026, the US Food and Drug Administration issued a Warning Letter to Belle Health LLC (Draper, Utah) citing violations of sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act. The FDA reviewed Belle Health's website in December 2025 and identified that Belle was displaying semaglutide and tirzepatide products with Belle branding in a way that suggested Belle itself manufactured or compounded the medications. Belle Health is a telehealth platform that connects patients with prescribers, not a compounding pharmacy — the actual compounding is performed by partner pharmacies. The FDA letter required Belle to correct the branding presentation to clearly identify the actual manufacturer/compounder of each product.

Patients evaluating Belle Health should be aware of this FDA action when comparing platforms. Cora Health has not received an FDA Warning Letter. Both companies operate as telehealth platforms that connect patients with licensed providers (Wasef Health, PC for Cora) and partner with US-licensed 503A compounding pharmacies (Hallandale Pharmacy and VialsRx for Cora; seven named pharmacies for Belle as of September 2026). Belle's product pages now state that Belle is not the compounding pharmacy or manufacturer. FDA Warning Letters are publicly searchable in the FDA Warning Letters database; patients evaluating any compounded GLP-1 telehealth provider can check current FDA enforcement status before signing up.

Who should choose Cora Health

Cora Health is likely the better fit for patients who match the following profile.

• Cash-pay patients who want a flat, all-in price for compounded GLP-1 on a 12-month commitment — compounded semaglutide at $99/month ($1,188 billed every 12 months) or compounded tirzepatide at $135/month ($1,620 billed every 12 months), each renewing automatically until cancelled
• Patients who prefer a subscription billing structure with 1, 3, 6, or 12-month commitment options
• Patients who want to know and verify the specific compounding pharmacy their medication comes from (Hallandale Pharmacy or VialsRx)
• Patients in any of the 50 US states (Cora ships nationwide)

Who should choose Belle Health

Belle Health is likely the better fit for patients who match the following profile.

• Cash-pay patients who want to pay for a full supply at checkout and value the weekly live dietitian group sessions Belle lists as included (joinbelle.com/treatments, checked September 23, 2026)
• Patients who want semaglutide on a 6-month supply, where Belle's $119/month is $1/month below Cora's 6-month rate
• Patients comfortable that an order cannot be refunded once it has gone to the pharmacy
• Patients in any of the 50 US states

Frequently asked questions

Common questions about the Cora Health vs Belle Health comparison.

Is Cora Health cheaper than Belle Health?

On 12-month plans, yes: Cora's annual plan is $99/month for compounded semaglutide vs Belle's $109/month (about 9% lower, $120/year), and $135/month for compounded tirzepatide vs Belle's $189/month (about 29% lower, $648/year). On 6-month plans Belle's semaglutide is $1/month lower ($119 vs $120) while Cora's tirzepatide is $24/month lower. Belle prices checked September 23, 2026; Cora plans renew automatically until cancelled.

Does Belle Health have a refund policy?

Yes. Belle's help center (checked September 23, 2026) says the card is charged in full at checkout, you are refunded in full if the prescription is not approved or the order is cancelled before it reaches the pharmacy, and an order cannot be refunded once it has gone to the pharmacy. Cora Health publishes its own refund policy at trycora.io/refund-policy.

Does Belle Health name its compounding pharmacy?

Yes. As of September 23, 2026, Belle lists seven partner pharmacies on its treatments page: Boudreaux's Specialty Compounding Pharmacy, BPI Labs, Hallandale Pharmacy, Hyalo Technologies, New Life Rx, ReviveRX and VialsRx; its GLP-1 listings include VialsRx. Cora Health names two US-licensed 503A pharmacies, Hallandale Pharmacy (PCAB-accredited) and VialsRx. Your medication label shows which pharmacy filled your order.

Are Belle Health and Cora Health both LegitScript certified?

Cora Health holds LegitScript certification at the platform level, verifiable on the LegitScript website. Belle Health says its medications are prepared by LegitScript-certified pharmacies; check the LegitScript checker for any company you are considering, since certification operates at different levels of the supply chain.

Sources & verification

All regulatory, clinical, pricing, and FDA enforcement claims in this article are verifiable against publicly accessible primary sources. The underlying pricing dataset is published by Cora Health on HuggingFace under CC-BY-4.0 license for independent verification and reuse. Belle pricing, pharmacy list and refund terms last verified 2026-09-23.

• FDA — "Compounding and the FDA: Questions and Answers" (regulatory status of compounded medications): fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
• FDA Warning Letter database (search for "Belle Health LLC" — February 2026 enforcement action referenced in this article): fda.gov warning letters database
• New England Journal of Medicine — STEP 1 (Wilding et al., 2021); 14.9% mean weight loss with FDA-approved 2.4mg semaglutide over 68 weeks: nejm.org/doi/full/10.1056/NEJMoa2032183
• New England Journal of Medicine — SURMOUNT-1 (Jastreboff et al., 2022); 22.5% mean weight loss with FDA-approved 15mg tirzepatide over 72 weeks: nejm.org/doi/full/10.1056/NEJMoa2206038
• CDC — Adult Obesity Facts (41.9% US prevalence per NHANES 2017–March 2020): cdc.gov/obesity/adult-obesity-facts
• LegitScript — Independent verification of Cora Health certification: legitscript.com/websites/?checker_keywords=trycora.io
• Pharmacy Compounding Accreditation Board (PCAB) — accreditation framework for compounding pharmacies: achc.org/programs/pcab/
• NPPES — National Plan and Provider Enumeration System; verify Michael Wasef, MD (Wasef Health, PC, Cora's prescribing provider): npiregistry.cms.hhs.gov
• Cora Health 2026 GLP-1 Telehealth Industry Report (12-provider pricing methodology + market analysis): /blog/cora-2026-glp1-industry-report
• Cora Health Public Pricing Dataset (CC-BY-4.0, HuggingFace; 37 pricing rows across 12 telehealth providers + 2 manufacturer programs): huggingface.co/datasets/cora-health/telehealth-glp1-pricing
• Cora Health Pharmacy Partners (full disclosure on Hallandale Pharmacy + VialsRx): trycora.io/pharmacy-partners
• Belle Health — pricing and partner pharmacies (checked 2026-09-23): joinbelle.com/treatments
• Belle Health help center — refunds and billing (checked 2026-09-23): help.joinbelle.com